ELANTAS BECK INDIA LTD.-$ (ELANTAS) Fair Value & Analysis
Basic Materials · IN · Market cap ₹79.8B
Fair value as of: Aug 16, 2026
From 26 valuation models · updated 4 days ago
Fair value updated Aug 16, 2026, revised from ₹2,865 to ₹2,390 (−16.6%) since Aug 11, 2026.
A solid business, but screening 79% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹3,446). The favourable scenario is already priced in.
- Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹1,480 to ₹3,446) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 16, 2026.
How to read this chart
60‑month range ₹3,231 – ₹14,471 · fair‑value band ₹1,480 – ₹3,446 · the ₹11,608 price screens above the ₹2,390 fair value. Dashed = 300-day average. As of Aug 16, 2026.
Analysis
ELANTAS BECK INDIA LTD.-$ (ELANTAS) currently trades at ₹11,608, while our model-based Fair Value estimate is ₹2,390, implying the stock looks roughly 79.4% overvalued today. The Quality Score stands at 64/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, ELANTAS BECK INDIA LTD.-$ generated revenue of ₹8.7B at a net margin of 16.8%. Revenue grew 7.8% year over year. It earns a return on equity of 15.8%. The stock trades on a trailing P/E of 63.0. Fundamentals as of Aug 16, 2026
Our scenario range runs from ₹1,480 (bear case) to ₹3,446 (bull case); at ₹11,608, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 63% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -68% fair-value upside, at -79%, ELANTAS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (₹3,077) versus Dividend Discount (₹120.74). Highest evidence: Residual Income (76).
Notify me when ELANTAS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 59
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
ELANTAS Beck India Limited manufactures and sells specialty chemicals for the electrical insulation and construction industries in India. It operates through two segments, Electrical Insulations, and Engineering & Electronic Resins and Materials.
Full company description
ELANTAS Beck India Limited manufactures and sells specialty chemicals for the electrical insulation and construction industries in India. It operates through two segments, Electrical Insulations, and Engineering & Electronic Resins and Materials. The company provides wire enamels, such as primers, lubricants, and binder varnishes for fiberglass coated conductors; impregnating materials, including insulating varnishes and resins; and flexible electrical insulation materials. It also offers casting and potting compounds comprising casting, potting, and encapsulation of electrical and electronic components, such as auto-electrical components, high-voltage insulators, instrument transformers, etc.; impregnation of high-voltage electrical machine windings; binder resins for glass-fibre filament wound arc chamber tubes; and diamond dotted paper for oil-filled transformers. In addition, the company provides electronic protection materials, including potting compounds, such as conformal, air drying resistant, rapid process acrylic, waterborne conformal, and silicone coatings; and thermal interface materials. Further, it offers engineering materials, such as construction chemicals comprising a range of resinous construction chemicals for industrial floorings, protective coatings, structural repairs, waterproofing, adhesives, and sealants, as well as specialty epoxy and polyurethane anti-microbial floorings; and reactive polyamides for the use in epoxy resins to produce top coats and primers, as well as thermosetting adhesives for a various substrates. The company was incorporated in 1956 and is based in Pune, India. ELANTAS Beck India Limited is a subsidiary of ELANTAS GmbH.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
ELANTAS BECK INDIA LTD.-$ reported revenue of ₹8.5B in FY2025 versus ₹5.2B in FY2021, a compound +12.9%/yr. Reported net income was ₹1.5B in FY2025, compounding +21.9%/yr from FY2021.
ELANTAS screens 79% overvalued. Compare with Linde plc →
Peer Group
Specialty Chemicals · 675 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $479.43 | $222.03 | -54% |
| Wanhua Chemical Group 600309 | ¥75.06 | ¥68.03 | -9% |
| Asian Paints Limited ASIANPAINT | ₹2,630 | ₹696.23 | -74% |
| Solar Industries India Limited SOLARINDS | ₹18,730 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,702 | ₹351.84 | -79% |
| PT Chandra Asri Pacific Tbk TPIA | 2,160 IDR | 2,322 IDR | +8% |
| Berger Paints India Limited BERGEPAINT | ₹541.00 | ₹156.35 | -71% |
| Gujarat Fluorochemicals Limited FLUOROCHEM | ₹4,680 | ₹724.88 | -85% |
| Himadri Speciality Chemical Limited HSCL | ₹778.15 | ₹248.63 | -68% |
| Enaex S.A ENAEX | 25,050 CLP | 23,574 CLP | -6% |
Compare ELANTAS BECK INDIA LTD.-$ with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is ELANTAS BECK INDIA LTD.-$ (ELANTAS) overvalued or undervalued?
What is the fair value of ELANTAS?
What is the quality score of ELANTAS?
What is the revenue of ELANTAS BECK INDIA LTD.-$ (ELANTAS)?
What is the net profit margin of ELANTAS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track ELANTAS BECK INDIA LTD.-$ and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.